Index of reports
> Hospitalization (180)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rituxan (Rituximab) hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 180 Next >>
Possible Rituxan side effects in 39 year old female
Reported by a pharmacist from United States on 2012-08-23
Patient: 39 year old female, weighing 82.6 kg (181.6 pounds)
Reactions: Dyspnoea, Vomiting, Chest Discomfort, Pruritus, Nausea, Rash, Infusion Related Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Prednisone; Pyroxidine; Calcium; Folic Acid; Leucovorin Calcium; Methotrexate; Ibuprofen; Lisinopril; Diazepam; Fexofenadine; Pantoprazole; Acetaminophen; Diphenhydramine Hydrochloride; Multi-Vitamin
Possible Rituxan side effects in male
Reported by a pharmacist from United States on 2012-08-20
Patient: male
Reactions: Tachycardia, Blood Pressure Decreased, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-20
Patient: female
Reactions: Pruritus, Visual Impairment, Oral Disorder, Psoriasis, Gingival Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in female
Reported by a individual with unspecified qualification from United States on 2012-08-20
Patient: female, weighing 70.4 kg (154.9 pounds)
Reactions: Movement Disorder, Dyspnoea, Local Swelling
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1280 mg
Doxorubicin Hydrochloride
Dosage: 86 mg
Prednisone
Dosage: 70 mg
Rituxan
Dosage: 650 mg
Vincristine Sulfate
Dosage: 2 mg
Possible Rituxan side effects in
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient:
Reactions: Weight Decreased, Unwanted Awareness During Anaesthesia, Dyspnoea, Lower Limb Fracture, Paraesthesia, Tremor, Irritability, Fatigue, Balance Disorder, Dizziness, Ulcer Haemorrhage, Papilloma Viral Infection, Nervousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Indication: non-Hodgkin's Lymphoma
Start date: 2005-01-01
Rituxan
Dosage: late dec/2011 or jan/2012
Possible Rituxan side effects in male
Reported by a physician from United States on 2012-08-16
Patient: male, weighing 84.7 kg (186.3 pounds)
Reactions: Splenic Vein Thrombosis, Venous Haemorrhage, Iatrogenic Injury, Splenic Neoplasm Malignancy Unspecified, Platelet Count Decreased, Gastric Varices, Haemorrhagic Ascites, Venous Injury
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1520 mg
Doxorubicin Hydrochloride
Dosage: 101 mg
Prednisone TAB
Dosage: 400 mg
Rituxan
Dosage: 758 mg
Vincristine Sulfate
Dosage: 2 mg
Possible Rituxan side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: female
Reactions: Thrombosis, RED Blood Cell Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Procrit
Indication: Product Used FOR Unknown Indication
Rituxan
Indication: Rheumatoid Arthritis
Possible Rituxan side effects in male
Reported by a physician from United States on 2012-08-16
Patient: male, weighing 84.7 kg (186.3 pounds)
Reactions: Splenic Vein Thrombosis, Abdominal Distension, Haemorrhagic Ascites, Venous Injury
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1520 mg
Doxorubicin Hydrochloride
Dosage: 101 mg
Prednisone
Dosage: 400 mg
Rituxan
Dosage: 758 mg
Vincristine Sulfate
Dosage: 2 mg
Possible Rituxan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15
Patient: male, weighing 91.7 kg (201.7 pounds)
Reactions: Pneumonia, Anaemia, Pancytopenia, Febrile Neutropenia, Respiratory Failure, Muscle Abscess, Thrombocytopenia, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: 150 milligram
Start date: 2012-05-14
Rituxan
Start date: 2012-06-22
Rituxan
Start date: 2012-07-19
End date: 2012-07-20
Rituxan
Dosage: 17.8571 milligram
Start date: 2012-08-04
Vidaza
Dosage: 150 milligram
Start date: 2012-05-14
Vidaza
Dosage: 150 milligram
Start date: 2012-07-19
End date: 2012-07-20
Other drugs received by patient: Procrit; Fluticasone Propionate; Folic Acid; Hydrocortisone-Pramoxine; Metoprolol Tartrate; Rosuvastatin; Meropenem; Vancomycin; Dextrose; Acetaminophen; Calcium + Vitamin D; Ciprofloxacin-Dexamethasone Otic; Diphenhydramine Hydrochloride; Filgrastim; Multi-Vitamins; Phenylephrine Hydrochloride; Acetaminophen; Naproxen; Whole Blood; Prednisone TAB; Vitamin B-12; Acetaminophen; Benazepril Hydrochloride; Augmentin '500'; Amlodipine; Omeprazole; Sodium Chloride
Possible Rituxan side effects in male
Reported by a physician from United States on 2012-08-14
Patient: male
Reactions: Aphasia, Unevaluable Event, Hemiparesis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in
Reported by a physician from China on 2012-08-14
Patient:
Reactions: Dyspnoea, Hyperpyrexia, Tachycardia, Oliguria, Altered State of Consciousness, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient: male
Reactions: Dyspnoea, Balance Disorder, Dizziness, Ulcer Haemorrhage, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in 70 year old
Reported by a pharmacist from United States on 2012-08-09
Patient: 70 year old
Reactions: Death, Histiocytosis Haematophagic, Chills
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Indication: Lymphoma
Start date: 2012-05-14
Bendamustine Hydrochloride
Start date: 2012-05-15
Rituxan
Dosage: splitted dose.
Start date: 2012-05-15
Rituxan
Indication: Lymphoma
Start date: 2012-05-14
Possible Rituxan side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-09
Patient: female
Reactions: Pneumonia, Diabetes Mellitus, Drug Ineffective, Condition Aggravated, Chronic Obstructive Pulmonary Disease, Dyspepsia, Oedema Peripheral, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone TAB
Start date: 2011-11-30
Prednisone TAB
Dosage: dose-variable. dose started years ago
Administration route: Oral
Indication: Vasculitis
Rituxan
Indication: Wegener's Granulomatosis
Start date: 2006-01-01
Rituxan
Indication: Vasculitis
Start date: 2011-08-25
End date: 2011-09-16
Other drugs received by patient: Simvastatin; Cellcept; Lisinopril; Metformin Hydrochloride
Possible Rituxan side effects in male
Reported by a physician from United States on 2012-08-07
Patient: male
Reactions: Malaise, Human Antichimeric Antibody Positive, Nuclear Magnetic Resonance Imaging Abnormal, B-Lymphocyte Count Decreased, Ill-Defined Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: treatment given once and repeated 2 weeks later.
Indication: Ill-Defined Disorder
Start date: 2010-10-01
Rituxan
Dosage: given once.
Start date: 2011-04-01
Rituxan
Dosage: given once.
Start date: 2012-03-01
Rituxan
Dosage: treatment repeated 1 week later
Start date: 2011-01-01
Rituxan
Dosage: given once.
Start date: 2011-10-01
Possible Rituxan side effects in female
Reported by a physician from United States on 2012-08-02
Patient: female, weighing 141.5 kg (311.3 pounds)
Reactions: Leukocytoclastic Vasculitis, Hypotension, Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in 1 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-25
Patient: 1 year old male, weighing 18.0 kg (39.6 pounds)
Reactions: Pneumonia Fungal, Electrocardiogram QT Prolonged, Renal Disorder, Malnutrition, Disseminated Intravascular Coagulation, Clostridium Colitis, Gastric Ulcer, Pneumonia Cytomegaloviral, Liver Disorder, Hypokalaemia, Pneumocystis Jiroveci Pneumonia, Pneumonia Bacterial, Pancreatitis, Acute Respiratory Distress Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ambisome
Dosage: uncertainty
Bactrim
Dosage: unk
Cellcept
Dosage: uncertainty
Administration route: Oral
Cyclosporine
Dosage: uncertainty
Decadron
Dosage: 12 mg, unk
Administration route: Oral
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2011-05-20
End date: 2011-06-17
Funguard
Dosage: uncertainty
Meropenem
Dosage: unk
Indication: Prophylaxis
Rituxan
Romiplostim
Dosage: 1 mg/kg, qwk
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2011-06-01
End date: 2011-06-08
Romiplostim
Dosage: 2 mg/kg, qwk
Start date: 2011-06-15
End date: 2011-06-15
Romiplostim
Dosage: 3 mg/kg, qwk
Start date: 2011-06-24
End date: 2012-06-24
Romiplostim
Dosage: 5 mg/kg, qwk
Start date: 2011-08-09
End date: 2011-08-09
Romiplostim
Dosage: 5 mg/kg, qwk
Start date: 2011-07-21
End date: 2011-08-06
Romiplostim
Dosage: 10 mg/kg, qwk
Start date: 2011-10-17
Romiplostim
Dosage: 9 mg/kg, qwk
Start date: 2011-09-08
End date: 2011-09-08
Romiplostim
Dosage: 4 mg/kg, qwk
Start date: 2011-07-11
End date: 2011-07-11
Romiplostim
Dosage: 8 mg/kg, qwk
Start date: 2011-09-01
End date: 2011-09-01
Romiplostim
Dosage: 3 mg/kg, qwk
Start date: 2012-06-21
End date: 2012-06-21
Romiplostim
Dosage: 6 mg/kg, qwk
Start date: 2011-08-16
End date: 2011-08-16
Romiplostim
Dosage: 7 mg/kg, qwk
Start date: 2011-08-24
End date: 2011-08-24
Romiplostim
Dosage: 10 mg/kg, qwk
Start date: 2011-09-15
End date: 2011-10-13
Zosyn
Dosage: unk
Other drugs received by patient: Prednisolone; Prednisolone; Fungizone; Prednisolone; Prednisolone; Prednisolone; Famotidine; Danazol; Danazol; Immune Globulin (Human); Cefazolin Sodium; Prednisolone; Prednisolone; Prednisolone; Prednisolone
Possible Rituxan side effects in male
Reported by a physician from United States on 2012-07-23
Patient: male
Reactions: Rash Generalised, Oedema, Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Indication: Mantle Cell Lymphoma
Start date: 2012-05-24
Bendamustine Hydrochloride
Start date: 2012-05-25
Rituxan
Indication: Mantle Cell Lymphoma
Possible Rituxan side effects in male
Reported by a physician from United States on 2012-07-23
Patient: male
Reactions: Rash Generalised, Oedema, Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Start date: 2012-05-25
Bendamustine Hydrochloride
Indication: Mantle Cell Lymphoma
Start date: 2012-05-24
Rituxan
Indication: Mantle Cell Lymphoma
Possible Rituxan side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-20
Patient: 66 year old female, weighing 85.8 kg (188.8 pounds)
Reactions: Atrial Fibrillation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: every 28 days
Start date: 2012-03-23
End date: 2012-05-03
Treanda
Dosage: every 28 days
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-03-23
End date: 2012-05-02
Possible Rituxan side effects in
Reported by a consumer/non-health professional from United States on 2012-07-17
Patient:
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carmustine
Dosage: day - 7
Cytarabine
Dosage: day -6 til day -3
Etoposide
Dosage: day -6 till day -3
Melphalan Hydrochloride
Dosage: day -2
Rituxan
Dosage: day - 19 and day - 12
Velcade
Dosage: d2 and d8
Indication: non-Hodgkin's Lymphoma
Start date: 2012-05-01
Vorinostat
Dosage: 200 mg, qd
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-04-30
End date: 2012-05-06
Other drugs received by patient: Zovirax; Diphenhydramine HCL; Loperamide HCL; Dapsone; Compazine; Cholecalciferol; Allegra; Citalopram Hydrobromide; Bactrim; Potassium Chloride; Vitamin D (Unspecified); Potassium Bicarbonate; Nystatin; Lorazepam; Zofran; Folic Acid; Vitamins (Unspecified)
Possible Rituxan side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-17
Patient: female, weighing 58.0 kg (127.6 pounds)
Reactions: Weight Decreased, Oral Candidiasis, Dehydration, Dizziness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1320 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-09
Cyclophosphamide
Dosage: 1350 mg, unk
Start date: 2012-01-23
Cyclophosphamide
Dosage: 1275 mg, unk
Start date: 2012-02-13
Doxorubicin HCL
Dosage: 88 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-09
Doxorubicin HCL
Dosage: 90 mg, unk
Start date: 2012-01-23
Doxorubicin HCL
Dosage: 85 mg, unk
Start date: 2012-02-13
Pegfilgrastim
Dosage: 6 mg, unk
Start date: 2012-02-14
Pegfilgrastim
Dosage: 6 mg, unk
Start date: 2012-01-28
Pegfilgrastim
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-10
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2012-01-23
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2012-02-13
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2012-02-17
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-23
Rituxan
Dosage: 600 mg, unk
Start date: 2012-02-18
Rituxan
Dosage: 600 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-09
Rituxan
Dosage: 700 mg, unk
Start date: 2012-01-23
Vincristine
Dosage: 42 mg, unk
Start date: 2012-01-23
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-09
Vincristine
Dosage: 2 mg
Start date: 2012-02-13
Other drugs received by patient: Morphine Sulfate; Pantoprazole; Mirtazapine; Tenoretic; Simvastatin; Venlafaxine Hydrocholride; Simvastatin; Simvastatin
Possible Rituxan side effects in 78 year old female
Reported by a physician from Denmark on 2012-07-16
Patient: 78 year old female, weighing 58.0 kg (127.6 pounds)
Reactions: Weight Decreased, Oral Candidiasis, Dehydration, Dizziness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1320 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-09
End date: 2012-01-01
Cyclophosphamide
Dosage: 1350 mg, unk
Start date: 2012-01-23
End date: 2012-01-01
Cyclophosphamide
Dosage: 1275 mg, unk
Start date: 2012-02-13
Doxorubicin HCL
Dosage: 88 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-09
Doxorubicin HCL
Dosage: 90 mg, unk
Start date: 2012-01-23
End date: 2012-01-01
Doxorubicin HCL
Dosage: 85 mg, unk
Start date: 2012-02-13
Neupogen
Dosage: 6 mg, unk
Start date: 2012-02-14
Neupogen
Dosage: 6 mg, unk
Start date: 2012-01-10
Neupogen
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-01-28
End date: 2012-01-01
Pegfilgrastim
Dosage: 6 mg, unk
Start date: 2012-02-14
Pegfilgrastim
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-10
Pegfilgrastim
Dosage: 6 mg, unk
Start date: 2012-01-28
End date: 2012-01-01
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2012-01-23
End date: 2012-01-01
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2012-02-13
End date: 2012-02-01
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-09
End date: 2012-01-01
Prednisone
Dosage: 50 mg, day 6
Prednisone
Dosage: 10 mg, day 8
Prednisone
Dosage: 25 mg, day 7
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2012-02-17
Rituxan
Dosage: 600 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-09
Rituxan
Dosage: 700 mg, unk
Start date: 2012-01-23
Rituxan
Dosage: 600 mg, unk
Start date: 2012-02-18
Vincristine
Dosage: 2 mg, unk
Start date: 2012-02-13
Vincristine
Dosage: 42 mg, unk
Start date: 2012-01-23
End date: 2012-01-01
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-09
End date: 2012-01-01
Other drugs received by patient: Mirtazapine; Simvastatin; Pantoprazole; Simvastatin; Simvastatin; Simvastatin; Tenoretic; Venlafaxine Hydrochloride; Morphine Sulfate
Possible Rituxan side effects in 68 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: 68 year old male, weighing 93.4 kg (205.6 pounds)
Reactions: Dyspnoea, Musculoskeletal Pain, Pancytopenia, Febrile Neutropenia, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: 750 milligram
Start date: 2012-06-22
Rituxan
Vidaza
Vidaza
Dosage: 150 milligram
Start date: 2012-05-14
Possible Rituxan side effects in 1 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-13
Patient: 1 year old male, weighing 18.0 kg (39.6 pounds)
Reactions: Electrocardiogram QT Prolonged, Pneumonia Fungal, Renal Disorder, Disseminated Intravascular Coagulation, Malnutrition, Gastric Ulcer, Clostridium Colitis, Pneumonia Cytomegaloviral, Hypokalaemia, Liver Disorder, Pneumocystis Jiroveci Pneumonia, Pneumonia Bacterial, Pancreatitis, Acute Respiratory Distress Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ambisome
Dosage: uncertainty
Bactrim
Dosage: unk
Cellcept
Dosage: uncertainty
Administration route: Oral
Cyclosporine
Dosage: uncertainty
Decadron
Dosage: 12 mg, unk
Administration route: Oral
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2011-05-20
End date: 2011-06-17
Funguard
Dosage: uncertainty
Meropenem
Dosage: unk
Indication: Prophylaxis
Rituxan
Romiplostim
Dosage: 3 mg/kg, qwk
Start date: 2011-06-24
End date: 2012-06-24
Romiplostim
Dosage: 10 mg/kg, qwk
Start date: 2011-09-15
End date: 2011-10-13
Romiplostim
Dosage: 2 mg/kg, qwk
Start date: 2011-06-15
End date: 2011-06-15
Romiplostim
Dosage: 5 mg/kg, qwk
Start date: 2011-07-21
End date: 2011-08-06
Romiplostim
Dosage: 6 mg/kg, qwk
Start date: 2011-08-16
End date: 2011-08-16
Romiplostim
Dosage: 5 mg/kg, qwk
Start date: 2011-08-09
End date: 2011-08-09
Romiplostim
Dosage: 10 mg/kg, qwk
Start date: 2011-10-17
Romiplostim
Dosage: 8 mg/kg, qwk
Start date: 2011-09-01
End date: 2011-09-01
Romiplostim
Dosage: 9 mg/kg, qwk
Start date: 2011-09-08
End date: 2011-09-08
Romiplostim
Dosage: 4 mg/kg, qwk
Start date: 2011-07-11
End date: 2011-07-11
Romiplostim
Dosage: 1 mg/kg, qwk
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2011-06-01
End date: 2011-06-08
Romiplostim
Dosage: 3 mg/kg, qwk
Start date: 2012-06-21
End date: 2012-06-21
Romiplostim
Dosage: 7 mg/kg, qwk
Start date: 2011-08-24
End date: 2011-08-24
Zosyn
Dosage: unk
Other drugs received by patient: Danazol; Famotidine; Prednisolone; Prednisolone; Danazol; Prednisolone; Cefazolin Sodium; Prednisolone; Immune Globulin (Human); Prednisolone; Fungizone; Prednisolone; Prednisolone; Prednisolone; Prednisolone
Possible Rituxan side effects in female
Reported by a physician from France on 2012-07-12
Patient: female, weighing 58.7 kg (129.1 pounds)
Reactions: Hypoglycaemia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Indication: Mantle Cell Lymphoma
Rituxan
Indication: Mantle Cell Lymphoma
Treanda
Indication: Mantle Cell Lymphoma
Velcade
Indication: Mantle Cell Lymphoma
Possible Rituxan side effects in 46 year old male
Reported by a physician from United States on 2012-07-12
Patient: 46 year old male
Reactions: Febrile Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 446 mg, unk
Cyclophosphamide
Dosage: 630 mg, q12h
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Doxorubicin HCL
Dosage: 56.5 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Doxorubicin HCL
Dosage: 37 mg, unk
Mesna
Dosage: 1116 mg, unk
Indication: non-Hodgkin's Lymphoma
Pegfilgrastim
Dosage: 6 mg, unk
Indication: non-Hodgkin's Lymphoma
Rituxan
Dosage: 698 mg, unk
Start date: 2012-05-02
Rituxan
Dosage: 787.5 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Other drugs received by patient: MS Contin; Valtrex; Omeprazole; Ciprofloxacin; Morphine Sulfate; Enoxaparin / 01708202 /; Compazine; Fluconazole; Metoprolol Tartrate
Possible Rituxan side effects in 82 year old female
Reported by a physician from France on 2012-07-10
Patient: 82 year old female
Reactions: Hypertension, Transient Ischaemic Attack
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Corticoid; Paroxetine HCL; Alendronate Sodium; Diltiazem HCL
Possible Rituxan side effects in male
Reported by a physician from Germany on 2012-07-10
Patient: male
Reactions: Neutropenia, Lymphocytic Infiltration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Doxorubicin HCL
Dosage: 100 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Neulasta
Dosage: 6 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-20
End date: 2012-04-20
Prednisolone
Dosage: 50 mg, bid
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-04-16
End date: 2012-04-21
Rituxan
Dosage: 750 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-16
End date: 2012-04-16
Vincristine
Dosage: 2 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Other drugs received by patient: Morphine Sulfate; Acyclovir; Metoclopramide; Dipyrone TAB; Pantoprazole
Possible Rituxan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10
Patient: male, weighing 48.5 kg (106.8 pounds)
Reactions: Myoclonus
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: 220 mg, single
Indication: Multiple Myeloma
Start date: 2012-06-06
End date: 2012-06-06
Rituxan
Dosage: 220 mg, single
Start date: 2012-05-30
End date: 2012-05-30
Zevalin
Dosage: 30.4 mci, single
Indication: Multiple Myeloma
Start date: 2012-06-06
End date: 2012-06-06
Zevalin
Dosage: 5.493 mci, single
Start date: 2012-05-30
End date: 2012-05-30
Other drugs received by patient: Folic Acid; Dexamethasone; Metoprolol; K-Phos Premix; Lasix; Magnesium Sulfate; Sodium Bicarbonate; Aspirin; Gabapentin; Nifedipine; Crestor; Ondansetron; Protonix; Melphalan Hydrochloride; Isosorbide Mononitrate; K-Phos Neutral; Levothyroxine Sodium
Page 1 Next >>
|